These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23184132)

  • 1. Low-level arsenic exposure is associated with bladder cancer risk and cigarette smoking: a case-control study among men in Tunisia.
    Feki-Tounsi M; Olmedo P; Gil F; Khlifi R; Mhiri MN; Rebai A; Hamza-Chaffai A
    Environ Sci Pollut Res Int; 2013 Jun; 20(6):3923-31. PubMed ID: 23184132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadmium in blood of Tunisian men and risk of bladder cancer: interactions with arsenic exposure and smoking.
    Feki-Tounsi M; Olmedo P; Gil F; Khlifi R; Mhiri MN; Rebai A; Hamza-Chaffai A
    Environ Sci Pollut Res Int; 2013 Oct; 20(10):7204-13. PubMed ID: 23673919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
    Tsuji JS; Alexander DD; Perez V; Mink PJ
    Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence.
    Christoforidou EP; Riza E; Kales SN; Hadjistavrou K; Stoltidi M; Kastania AN; Linos A
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(14):1764-75. PubMed ID: 24007431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential effect modifiers of the arsenic-bladder cancer risk relationship.
    Koutros S; Baris D; Waddell R; Beane Freeman LE; Colt JS; Schwenn M; Johnson A; Ward MH; Hosain GM; Moore LE; Stolzenberg-Solomon R; Rothman N; Karagas MR; Silverman DT
    Int J Cancer; 2018 Dec; 143(11):2640-2646. PubMed ID: 29981168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
    Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
    J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.
    Beebe-Dimmer JL; Iyer PT; Nriagu JO; Keele GR; Mehta S; Meliker JR; Lange EM; Schwartz AG; Zuhlke KA; Schottenfeld D; Cooney KA
    Environ Health; 2012 Jun; 11():43. PubMed ID: 22747749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumption of low-moderate level arsenic contaminated water does not increase spontaneous pregnancy loss: a case control study.
    Bloom MS; Neamtiu IA; Surdu S; Pop C; Lupsa IR; Anastasiu D; Fitzgerald EF; Gurzau ES
    Environ Health; 2014 Oct; 13():81. PubMed ID: 25311704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
    Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
    Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic methylation and bladder cancer risk in Taiwan.
    Chen YC; Su HJ; Guo YL; Hsueh YM; Smith TJ; Ryan LM; Lee MS; Christiani DC
    Cancer Causes Control; 2003 May; 14(4):303-10. PubMed ID: 12846360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic methylation and lung and bladder cancer in a case-control study in northern Chile.
    Melak D; Ferreccio C; Kalman D; Parra R; Acevedo J; Pérez L; Cortés S; Smith AH; Yuan Y; Liaw J; Steinmaus C
    Toxicol Appl Pharmacol; 2014 Jan; 274(2):225-31. PubMed ID: 24296302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-level arsenic exposure in drinking water and bladder cancer: a review and meta-analysis.
    Mink PJ; Alexander DD; Barraj LM; Kelsh MA; Tsuji JS
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):299-310. PubMed ID: 18783726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic, tobacco smoke, and occupation: associations of multiple agents with lung and bladder cancer.
    Ferreccio C; Yuan Y; Calle J; Benítez H; Parra RL; Acevedo J; Smith AH; Liaw J; Steinmaus C
    Epidemiology; 2013 Nov; 24(6):898-905. PubMed ID: 24036609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
    Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
    Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.
    Meliker JR; Slotnick MJ; AvRuskin GA; Schottenfeld D; Jacquez GM; Wilson ML; Goovaerts P; Franzblau A; Nriagu JO
    Cancer Causes Control; 2010 May; 21(5):745-57. PubMed ID: 20084543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland.
    Kurttio P; Pukkala E; Kahelin H; Auvinen A; Pekkanen J
    Environ Health Perspect; 1999 Sep; 107(9):705-10. PubMed ID: 10464069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.
    Mendez WM; Eftim S; Cohen J; Warren I; Cowden J; Lee JS; Sams R
    J Expo Sci Environ Epidemiol; 2017 May; 27(3):235-243. PubMed ID: 27901016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic-related chromosomal alterations in bladder cancer.
    Moore LE; Smith AH; Eng C; Kalman D; DeVries S; Bhargava V; Chew K; Moore D; Ferreccio C; Rey OA; Waldman FM
    J Natl Cancer Inst; 2002 Nov; 94(22):1688-96. PubMed ID: 12441324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 alterations in bladder tumors from arsenic and tobacco exposed patients.
    Moore LE; Smith AH; Eng C; DeVries S; Kalman D; Bhargava V; Chew K; Ferreccio C; Rey OA; Hopenhayn C; Biggs ML; Bates MN; Waldman FM
    Carcinogenesis; 2003 Nov; 24(11):1785-91. PubMed ID: 12919957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-control study of bladder cancer and arsenic in drinking water.
    Bates MN; Smith AH; Cantor KP
    Am J Epidemiol; 1995 Mar; 141(6):523-30. PubMed ID: 7900719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.